Stefano Biondi,MRSC CChem
Member of the executive team of
Allecra Therapeutics SAS, a startup company focused on the development
of novel antibiotics.
Founder of Innovative Solution a medicinal and pharmaceutical
chemistry consultancy company.
More than 20 years of professional experience in Pharma and Biotech
companies as medicinal and pharmaceutical chemist.
15 years as
scientist and laboratory head in antibacterial research at
Bring experience in natural and semi-synthetic product development
including chemical modification of genetically bioengineered
3 years in Neuro3D a French start-up company as chemistry R&D
director dealing with lead optimization and chemical and
pharmaceutical development of CNS drugs.
From 2005 till 2009 Director of Research Laboratories at Nicox,
managing chemistry and pharmacology. Contributed to the discovery
and development of numerous nitric oxide releasing compounds.
From sept 2011 till jan 2013 co-founder and CEO of TheraBor
Pharmaceuticals a privately owned spinout from the University of
Modena & Reggio Emilia based on its proprietary platform of boronic
acids to solve the problem of resistance to antibiotics (www.therabor.it).
Inventor of over 40 patents and 20 scientific papers, including Anti-infectives, CNS,
Cardiovascular, Ophthalmic and Anti inflammatory drugs.